BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7380136)

  • 1. Combination antitumor effect with central nervous system depressants on rat ascites hepatomas.
    Koshiura R; Miyamoto K; Sanae F
    Gan; 1980 Feb; 71(1):45-51. PubMed ID: 7380136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comination effect of reserpine with antitumor agents in L1210.
    Miyamoto K; Wakusawa S; Koshura R
    Gan; 1980 Jun; 71(3):408-14. PubMed ID: 7418986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suggestive evidence for relationship between sensitivity and repair capability in rat ascites hepatoma cells treated with the antitumor agent, 1-(gamma-chloropropyl)-2-chloromethylpiperidine hydrobromide.
    Fukuda S; Koshiura R; Miyamoto K; Hatano M
    Gan; 1977 Apr; 68(2):175-82. PubMed ID: 196969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of sensitivity and uptake of vinblastine by reserpine in rat ascites hepatoma.
    Wakusawa S; Miyamoto K; Koshiura R
    Jpn J Pharmacol; 1984 Oct; 36(2):187-95. PubMed ID: 6513200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of iproniazid on the combination effect of reserpine with antitumor agents on l1210.
    Wakusawa S; Miyamoto K; Koshiura R
    Gan; 1982 Aug; 73(4):637-41. PubMed ID: 7152199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of 2,6-bis(halomethyl)piperidines on rat ascites hepatomas.
    Miyamoto K; Sanae F; Koshiura R
    Gan; 1978 Oct; 69(5):703-7. PubMed ID: 729968
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antitumor spectrum of TUT-7 on rat ascitic hepatoma].
    Satoh H; Taguchi H; Yahagi S
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):287-91. PubMed ID: 2137321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First experiments with locoregional chemotherapy in the treatment of autochthonous rat hepatoma.
    Rozycki-Gerlach W; Berger MR; Friedl P; Yi J; Schmähl D; Schlag P
    Arch Geschwulstforsch; 1988; 58(6):369-78. PubMed ID: 2464971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of antitumor activity of cyclophosphamide by centrophenoxine.
    Kanzawa F; Hoshi A; Tsuda S; Kuretani K
    Gan; 1972 Aug; 63(4):409-13. PubMed ID: 4404224
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo.
    Mourelatos D; Dozi-Vassiliades J; Kotsis A; Gourtsas C
    Cancer Res; 1988 Mar; 48(5):1129-31. PubMed ID: 3342394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat hepatomas: chemotherapy with lycurim and pyrazofurin.
    Lui MS; Jackson RC; Harkrader RJ; Weber G
    J Natl Cancer Inst; 1982 Apr; 68(4):665-8. PubMed ID: 6951080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Overcoming of ACNU resistance in a subline of rat glioma in vitro and in vivo by reserpine].
    Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Sakamoto Y
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2141-6. PubMed ID: 3459396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental studies on the antitumor effect of progesterone and enhancement of the therapeutic effect of anticancer drugs by progesterone--from the aspect of zinc metabolism].
    Ujiie S; Mimata Y; Okuno M; Wakui A
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2423-8. PubMed ID: 2751319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitumor spectrum of 7-N-(p-hydroxyphenyl) mitomycin C (KW 2083) in rat ascites hepatoma].
    Sato H; Taguchi H; Kobayashi Y
    Gan No Rinsho; 1982; 28(2):122-4. PubMed ID: 6820669
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antineoplastic spectrum of mitoxantrone in rat ascitic hepatoma].
    Satoh H
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):26-30. PubMed ID: 7184361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of 6-keto prostaglandin E1 on the ascitic hepatoma-130 in vivo. Comparison with chemotherapeutic agent].
    Hiroshi K; Masanori O; Kaoru A; Gompachi Y; Hiroshi S
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1598-604. PubMed ID: 6089667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
    Holm B; Jensen PB; Sehested M
    Cancer Chemother Pharmacol; 1996; 38(3):203-9. PubMed ID: 8646793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor effect of polysaccharide lentinan on C3H/He mice bearing MH134 ascites hepatoma].
    Moriyama M; Miwa H; Moriya N; Orita K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1102-7. PubMed ID: 6820909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
    Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
    Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
    Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
    Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.